DNAJC10 and glioblastoma: Additionally, Clinical Proteomic Tumor Analysis Consortium (CPTAC) proteogenomic GBM dataset confirmed higher DNAJC10 protein levels correlated with longer OS and recurrence-free survival (RFS) (Fig. 1g-i).